Variant report
Variant | esv1835512 |
---|---|
Chromosome Location | chr9:105732153-105761490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:53)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr9:105732789-105732939 | K562 | blood: | n/a | n/a |
2 | CTCF | chr9:105747084-105747155 | GM13976 | blood: | n/a | n/a |
3 | CTCF | chr9:105754978-105755001 | GM13977 | blood: | n/a | n/a |
4 | E2F4 | chr9:105744253-105744566 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | E2F4 | chr9:105752889-105753300 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | E2F4 | chr9:105749194-105749374 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | E2F4 | chr9:105748472-105748633 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | ESR1 | chr9:105747816-105748084 | ECC-1 | luminal epithelium: | n/a | n/a |
9 | ESR1 | chr9:105747697-105748193 | ECC-1 | luminal epithelium: | n/a | n/a |
10 | ESR1 | chr9:105747761-105748124 | ECC-1 | luminal epithelium: | n/a | n/a |
11 | ESR1 | chr9:105747764-105748093 | ECC-1 | luminal epithelium: | n/a | n/a |
12 | FOS | chr9:105736410-105737308 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr9:105736821-105737182 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOS | chr9:105736811-105737195 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | FOS | chr9:105744172-105744657 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr9:105744161-105744663 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr9:105736573-105737183 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr9:105744359-105744579 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr9:105744233-105744638 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOSL2 | chr9:105736773-105737181 | MCF-7 | breast: | n/a | n/a |
21 | FOSL2 | chr9:105736908-105737052 | A549 | lung: | n/a | n/a |
22 | GATA3 | chr9:105761031-105761219 | SH-SY5Y | brain: | n/a | n/a |
23 | GATA3 | chr9:105736748-105737282 | MCF-7 | breast: | n/a | n/a |
24 | JUN | chr9:105736889-105737033 | HepG2 | liver: | n/a | n/a |
25 | JUND | chr9:105736848-105737171 | HepG2 | liver: | n/a | chr9:105736998-105737009 |
26 | JUND | chr9:105736989-105737012 | K562 | blood: | n/a | chr9:105736998-105737009 |
27 | JUND | chr9:105736736-105737299 | MCF-7 | breast: | n/a | chr9:105736998-105737009 |
28 | JUND | chr9:105754376-105754643 | HepG2 | liver: | n/a | n/a |
29 | KAP1 | chr9:105732605-105733109 | K562 | blood: | n/a | n/a |
30 | POLR2A | chr9:105755553-105755771 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr9:105746613-105746810 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr9:105748700-105748787 | Gliobla | brain: | n/a | n/a |
33 | POLR2A | chr9:105756798-105756808 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr9:105756169-105756243 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr9:105740094-105740164 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | POLR2A | chr9:105747654-105747673 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr9:105751955-105751968 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr9:105757552-105757684 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr9:105737891-105738355 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | REST | chr9:105751106-105751212 | PANC-1 | pancreas: | n/a | n/a |
41 | SETDB1 | chr9:105732728-105733109 | U2OS | brain: | n/a | n/a |
42 | STAT3 | chr9:105736982-105736990 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | STAT3 | chr9:105748537-105748540 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | STAT3 | chr9:105744250-105744562 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | STAT3 | chr9:105735108-105735259 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | STAT3 | chr9:105748447-105748597 | MCF10A-Er-Src | breast: | n/a | chr9:105748491-105748502 |
47 | STAT3 | chr9:105761255-105761535 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | STAT3 | chr9:105744285-105744538 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr9:105744228-105744562 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr9:105751507-105751707 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYLC2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7859859 | chr9:105747570-105747571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs147796474 | chr9:105747619-105747620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78350186 | chr9:105747625-105747626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533970942 | chr9:105747655-105747656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117257851 | chr9:105747685-105747686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187889375 | chr9:105747783-105747784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148886440 | chr9:105747797-105747798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544269775 | chr9:105747839-105747840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77403962 | chr9:105747861-105747862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571907937 | chr9:105747901-105747902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531752358 | chr9:105747932-105747933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148066906 | chr9:105747954-105747955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140866064 | chr9:105747957-105747958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145643682 | chr9:105747958-105747959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556146964 | chr9:105747963-105747964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376479632 | chr9:105748028-105748029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76446704 | chr9:105748114-105748115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538583068 | chr9:105748167-105748168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138172554 | chr9:105748178-105748179 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571959566 | chr9:105748181-105748182 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549052268 | chr9:105748183-105748184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10760930 | chr9:105748184-105748185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142762768 | chr9:105748188-105748189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371929777 | chr9:105748198-105748199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574099358 | chr9:105748200-105748201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145078024 | chr9:105748214-105748215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10739860 | chr9:105748222-105748223 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs531725530 | chr9:105748287-105748288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193090085 | chr9:105748311-105748312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369329645 | chr9:105748328-105748329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527948153 | chr9:105748378-105748379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7874072 | chr9:105748396-105748397 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs564305579 | chr9:105748415-105748416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1592242 | chr9:105748480-105748481 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs529825335 | chr9:105748504-105748505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376696988 | chr9:105748505-105748506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550225914 | chr9:105748508-105748509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569351802 | chr9:105748533-105748534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538247052 | chr9:105748564-105748565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568493784 | chr9:105748567-105748568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558086830 | chr9:105748589-105748590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185065028 | chr9:105748602-105748603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565649294 | chr9:105748627-105748628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534581970 | chr9:105748631-105748632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529276524 | chr9:105748661-105748662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554775331 | chr9:105748671-105748672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574528991 | chr9:105748686-105748687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149411252 | chr9:105748687-105748688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556689345 | chr9:105748732-105748733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116145477 | chr9:105748747-105748748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:105747400-105748000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr9:105747400-105749200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr9:105747600-105747800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr9:105747800-105748600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
5 | chr9:105747800-105748800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr9:105747800-105749200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr9:105748000-105748200 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr9:105748400-105749200 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr9:105748400-105749200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr9:105748600-105749200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr9:105748600-105749200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr9:105748800-105749000 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr9:105748800-105749400 | Enhancers | HUES48 Cell Line | embryonic stem cell |